Add like
Add dislike
Add to saved papers

Radiofrequency thermal ablation of renal graft neoplasms: case series and literature review.

Clinical Transplantation 2018 October 25
PURPOSE: To evaluate the feasibility, safety, and effectiveness of minimally invasive percutaneous radiofrequency thermal ablation (RFA) in renal graft neoplasms.

METHODS: Three patients with transplanted kidney neoplasms were treated in our Centre with US-guided RFA; pre- and post-procedural serum creatinine levels were registered, as well as peri-procedural and long-term minor and major complications and deaths. Patients underwent laboratory and CT follow-up to the renal function and tumour response evaluation, respectively.

RESULTS: All patients were successfully treated, with a complete necrosis of the target lesion, a low rate of complications, and no significative alterations in post-procedural serum creatinine levels. Two patients underwent a 1-year follow-up, with stable complete response.

CONCLUSIONS: RFA of renal graft neoplasms is a feasible, safe, and effective treatment. This procedure should be considered as a viable therapeutic option, granting good results, and preserving renal function. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app